These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4832648)

  • 1. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
    Denys A; Kowalska M; Szydłowska T; Białek J
    Pol Tyg Lek; 1986 May; 41(19):619-23. PubMed ID: 3763446
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
    Conley FK
    J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunology of experimental osteosarcoma.
    Ghanta VK; Hiramoto RN; Weiss AB; Caudill L; Davis DW
    Clin Orthop Relat Res; 1978 Jun; (133):246-60. PubMed ID: 278687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional immunotherapy of brain tumors with combined Corynebacterium parvum and recombinant interleukin-2 in mice.
    Conley FK; Adler JR; Duncan JA; Kennedy JD; Sutton RC
    J Natl Cancer Inst; 1990 Aug; 82(16):1340-4. PubMed ID: 2380991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Immunological control of cancer.
    Israel L; Edelstein R
    Lancet; 1975 Apr; 1(7913):979-10. PubMed ID: 48154
    [No Abstract]   [Full Text] [Related]  

  • 11. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
    Ocenásková J; Mára M; Bednár M; Veselská M; Adamcová D
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):100-6. PubMed ID: 3157461
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
    Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
    Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B; Wolmark N; Saffer E; Fisher ER
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice.
    Houchens DP; Goldberg AI; Gaston MR; Kende M; Goldin A
    Cancer Res; 1973 Apr; 33(4):685-90. PubMed ID: 4696469
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitory action of Corynebacterium parvum on the development of malignant syngenic tumors, and its mechanism].
    Halpern B; Fray A; Crepin Y; Platica O; Sparros L; Lorinet AM; Rabourdin A
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1911-5. PubMed ID: 4201539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.